​

Funding Round

Series B - Envisagenics

Series B - Envisagenics

Investment Firm

Overview

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Announced Date

Jun 04, 2024

Funding Type

Series B

Highlights

Location

New York, United States, North America

Social

Investor Lead

Red Cell Partners

Red Cell Partners

Red Cell Partners is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorRed Cell Partners
Participant InvestorEmpire State Development
Participant InvestorThird Kind Venture Capital
Participant InvestorBristol-Myers Squibb

Round Details and Background

Envisagenics raised $25000000 on 2024-06-04 in Series B

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Company Funding History

14

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 04, 2024
Series B - Envisagenics
4-25.0M
Jul 01, 2016
Non Equity Assistance - Envisagenics
1-undefined
Aug 13, 2015
Grant - Envisagenics
1-225.0K
Jul 29, 2015
Pre Seed Round - Envisagenics
1-50.0K

Recent Activity

There is no recent news or activity for this profile.